← Clinical Evidence

SRC-069e9a832384 Schini M 2023

Evidence source and scope

Increased fracture risk in Parkinson’s disease - An exploration of mechanisms and consequences for fracture prediction with FRAX.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1016/j.bone.2022.116651

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Schini M, Bhatia P, Shreef H, et al. Increased fracture risk in Parkinson’s disease: an exploration of mechanisms and consequences for fracture prediction with FRAX. Bone. 2023;168:116651. Original article

Schini M, Bhatia P, Shreef H, Johansson H, Harvey NC, Lorentzon M, et al. Increased fracture risk in Parkinson’s disease: An exploration of mechanisms and consequences for fracture prediction with FRAX. Bone. 2023;168:116651. DOI 10.1016/j.bone.2022.116651

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-69-03

STR-69-01

STR-69-02

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease — transfer

5,212 women aged ≥75, 47 with PD; 11 PD women sustained 12 fractures. Nurse-observed single armless rise uses three ability categories. PD hazard ratio adjusted for STS 2.16 (1.19–3.93), n=5,158; strength-adjusted HR 1.70 (.81–3.59), n=4,611 versus base n=5,161. Original supplement concerns sway.

Limitations: Only the enumerated transfer-relevant components were adjudicated. Source availability does not imply every statement, supplement, figure or raw datum was checked.

Parkinson’s disease strength

Parkinson’s disease strength component — Fracture sample definition, force assay, hazard-ratio exposure and exact model denominators

The cohort comprises women aged≥75 years; Results gives 43 definite PD cases plus four probable cases receiving dopaminergic treatment. An in-house load cell measured maximum isometric quadriceps force bilaterally. Table 2 treats PD status as the exposure: height/treatment-adjusted HR 2.25 [1.24, 4.08], n 5161, versus HR 1.70 [.81, 3.59], n 4611 after adding quadriceps strength. Different model samples prevent attributing all attenuation to strength. The report’s values and interpretation match.

Source locator: https://doi.org/10.1016/j.bone.2022.116651; Library original archived audit evidence Methods2.1–2.4, Results3.1, Table2 and footnote

Limitations: AI-assisted comparison with archived licensed capture; transcription accuracy was not independently verified against the live publisher original.

Parkinson’s disease strength component — Recovered supplement content and historical-access boundary

The separately recovered original Schini supplement contains only a sway-path comparison table. It adds no per-strength fracture hazard ratio or chair-rise prognostic model. All strength-related numeric claims in P 502 are in main Table 2, already checked. A licensed archived source now supports current access; this does not reproduce the report author’s original reading process.

Source locator: https://doi.org/10.1016/j.bone.2022.116651; archived audit evidence

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide